Prestige Consumer Healthcare: brands it owns and its ownership tree
Prestige Consumer Healthcare (NYSE: PBH) is a publicly listed company headquartered in Tarrytown, New York, United States that owns 6 consumer brands across 2 categories, and has 1 recorded transaction.[1][2]
Prestige Consumer Healthcare buys established over-the-counter medicine brands that larger pharmaceutical companies no longer want to promote, and runs them with low overheads and targeted advertising. Almost its entire portfolio was acquired rather than developed.
What Prestige Consumer Healthcare's annual report says about its business
Read from Prestige Consumer Healthcare's latest annual filing[1]. Each line gives the sentence the filing uses, copied word for word.
Segments the filing names
North American OTC Healthcare, International OTC Healthcare: At March 31, 2026 and 2025, goodwill and intangible assets were apportioned among similar product groups within our operating segments as follows: 35 March 31, 2026 (In thousands) North American OTC Healthcare International OTC Healthcare Consolidated
Acquisitions and disposals named in the filing
Acquired: Arnprior Ontario, Canada facility. As part of our recent acquisition of our Arnprior Ontario, Canada facility from our primary Clear Eyes supplier, we have committed to a long-term investment including a number of plant enhancements and capital investments, which may at times negatively impact production in the short-term but improve production over time.
Acquired: Pillar5 (December 18, 2025). On December 18, 2025, we completed the acquisition of Pillar5, which was funded through a combination of cash on hand and our existing asset-based revolving credit facility.
Sold or exited: Revelyst, Inc.. Jazz Pharmaceuticals PLC, Primo Brands and Revelyst, Inc., which were included in the Old Peer Group, were replaced in the New Peer Group as they ceased to be relevant peers because their financial profiles no longer provided meaningful comparables and Revelyst, Inc. was split and sold.
Prestige Consumer Healthcare in numbers
Prestige Consumer Healthcare owns 6 consumer brands tracked here across 2 top-level categories; the largest is consumer health with 5 brands.[1]
1 recorded acquisitions, 1 of them completed since 2015; disclosed US-dollar deal values total $1.04 billion.
Prestige Consumer Healthcare financial history
Headline figures from Prestige Consumer Healthcare's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2021–2026.
Revenue moved from $943.4m to $1.09bn, an average of 2.9% a year (calculated).
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Everything Prestige Consumer Healthcare owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Prestige Consumer Healthcare bought the Breathe Right nasal strip brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, about $900 million after $150 million of expected tax benefits, and closed on 15 June 2026. When the deal was announced Prestige also named Dimetapp and Anbesol among the brands included. It is a characteristic Prestige purchase: an established over-the-counter name bought from a private owner rather than a brand built from scratch.
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy